Friday, 20 February 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 20 February 2026
News

Novo boss comes out swinging

 Posted 11 August 2025 AM

Within hours of taking on the top job at Novo Nordisk, new CEO Mike Doustdar has come out fighting, frankly addressing the company's challenges and laying out his plans to "play to win".

The company's sixth CEO, Doustdar takes the helm at a critical time, with Novo's performance coming under increasing scrutiny from investors as share prices fall in the face of stiff competition.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (3)

Other (17)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.